Serefoglu EC - Search Results

1

Chronic escitalopram treatment induces erectile dysfunction by decreasing nitric oxide bioavailability mediated by increased nicotinamide adenine dinucleotide phosphate oxidase activity and reactive oxygen species production.

Kassan M, Lasker GF, Sikka SC, Mandava SH, Gokce A, Matrougui K, Hellstrom WJ, Kadowitz PJ, Serefoglu EC. Kassan M, et al. Among authors: serefoglu ec. Urology. 2013 Nov;82(5):1188.e1-7. doi: 10.1016/j.urology.2013.07.037. Epub 2013 Oct 25. Urology. 2013. PMID: 24242893

2

Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.

Serefoglu EC, Smith TM, Kaufman GJ, Liu G, Yafi FA, Hellstrom WJG. Serefoglu EC, et al. Urology. 2017 Sep;107:155-160. doi: 10.1016/j.urology.2017.05.029. Epub 2017 May 26. Urology. 2017. PMID: 28554517 Free article. Clinical Trial.

3

Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis.

Mandava SH, Serefoglu EC, Freier MT, Wilson SK, Hellstrom WJ. Mandava SH, et al. Among authors: serefoglu ec. J Urol. 2012 Nov;188(5):1855-60. doi: 10.1016/j.juro.2012.07.022. Epub 2012 Sep 19. J Urol. 2012. PMID: 22999690 Review.

4

Treatment of Peyronie's disease: 2012 update.

Serefoglu EC, Hellstrom WJ. Serefoglu EC, et al. Curr Urol Rep. 2011 Dec;12(6):444-52. doi: 10.1007/s11934-011-0212-2. Curr Urol Rep. 2011. PMID: 21818660 Review.

5

Re: long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup: C. C. Carson, III, J. J. Mulcahy and M. R. Harsch, J Urol 2011; 185: 614-618.

Serefoglu EC, Mandava SH, Hellstrom WJ. Serefoglu EC, et al. J Urol. 2012 May;187(5):1936-7. doi: 10.1016/j.juro.2011.12.115. Epub 2012 Mar 19. J Urol. 2012. PMID: 22436103 No abstract available.

6

Sexual dysfunction following radical prostatectomy.

Benson CR, Serefoglu EC, Hellstrom WJ. Benson CR, et al. Among authors: serefoglu ec. J Androl. 2012 Nov-Dec;33(6):1143-54. doi: 10.2164/jandrol.112.016790. Epub 2012 Jun 28. J Androl. 2012. PMID: 22744864 Review.

7

PDE5 inhibitor treatment options for urologic and non-urologic indications: 2012 update.

Gur S, Kadowitz PJ, Serefoglu EC, Hellstrom WJ. Gur S, et al. Among authors: serefoglu ec. Curr Pharm Des. 2012;18(34):5590-606. doi: 10.2174/138161212803307554. Curr Pharm Des. 2012. PMID: 22747425 Review.

8

The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Serefoglu EC, Trost L, Sikka SC, Hellstrom WJ. Serefoglu EC, et al. Int J Impot Res. 2015 Jan-Feb;27(1):6-8. doi: 10.1038/ijir.2014.25. Epub 2014 Jul 17. Int J Impot Res. 2015. PMID: 25030909

9

Long-term revision rate due to infection in hydrophilic-coated inflatable penile prostheses: 11-year follow-up.

Serefoglu EC, Mandava SH, Gokce A, Chouhan JD, Wilson SK, Hellstrom WJ. Serefoglu EC, et al. J Sex Med. 2012 Aug;9(8):2182-6. doi: 10.1111/j.1743-6109.2012.02830.x. Epub 2012 Jul 3. J Sex Med. 2012. PMID: 22759917

10

A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction.

Hellstrom WJ, Freier MT, Serefoglu EC, Lewis RW, DiDonato K, Peterson CA. Hellstrom WJ, et al. Among authors: serefoglu ec. BJU Int. 2013 Jan;111(1):137-47. doi: 10.1111/j.1464-410X.2012.11267.x. Epub 2012 Jul 12. BJU Int. 2013. PMID: 22788525 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page